This document provides guiding principles on the use of general-purpose large language models (LLM) in regulatory science and for regulatory activities and provides high-level recommendations to regulatory authorities to facilitate the safe, responsible and effective use of LLMs.
News & Trends
Procurar
Recentes
- Digital label for authorised representative and importer
- MANUAL PARA REGULARIZAÇÃO DE EQUIPAMENTO MÉDICO E SOFTWARE COMO DISPOSITIVO MÉDICO NA ANVISA
- How to Prepare a PreRequest for Designation (Pre-RFD) . FDA Guidance for Industry
- Formação exclusiva Formiventos CTD MODULO 3: “Evento de alta qualidade que permitiu grande interação entre todos os participantes. “
- PREÇOS 2025: “Muito interessante e enriquecedora”
- GUIDANCE DOCUMENT Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications
- FDA Releases Draft Guidance on Quality Management System (QMS) Requirements for Premarket Submissions (October 2025
- FARMACOVIGILÂNCIA avançada: ““Excelente! Organizada e abrangente !”

